Neutrons reveal unpredicted binding between SARS-CoV-2, hepatitis C antiviral drug ...Middle East

Researchers at the Oak Ridge National Laboratory used neutron scattering to investigate the interactions between telaprevir, a drug used to treat hepatitis C viral infection, and the SARS-CoV-2 main protease, the enzyme responsible for enabling the virus to reproduce. Unforeseen changes in the electric charges were discovered in the drug binding site of the protease enzyme that were not predicted by prevailing computer simulations. The research provides key insights for advancing drug design and drug repurposing efforts to treat COVID-19.

Hence then, the article about neutrons reveal unpredicted binding between sars cov 2 hepatitis c antiviral drug was published today ( Tuesday 23/03/2021 - 10:45 PM ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Neutrons reveal unpredicted binding between SARS-CoV-2, hepatitis C antiviral drug )

Also on site :

• PIN Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Pinterest, Inc.
• Sheena Easton, 66, Is Still a Stunning Redhead Several Years After Leaving the Chaos of Mega-Fame Behind
• ‘Murphy Brown’ Star Jessie Jones Dead at 75